Mednax Inc Stock Performance
| MD Stock | USD 14.75 0.26 1.79% |
On a scale of 0 to 100, Mednax holds a performance score of 10. The company secures a Beta (Market Risk) of 1.72, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Mednax will likely underperform. Please check Mednax's downside variance, day median price, and the relationship between the treynor ratio and kurtosis , to make a quick decision on whether Mednax's current price movements will revert.
Risk-Adjusted Performance
10 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Mednax Inc are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady fundamental indicators, Mednax exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 1.04 | Five Day Return (1.28) | Year To Date Return 56.08 | Ten Year Return (77.09) | All Time Return 173.96 |
Last Split Factor 2:1 | Last Split Date 2013-12-20 |
1 | Disposition of 11100 shares by Swift James D of Mednax at 10.79 subject to Rule 16b-3 | 08/30/2024 |
2 | Insider Trading | 10/01/2024 |
3 | Pediatrix Medical Group 2024 Third Quarter Conference CallWebcast Scheduled for Friday, November 1, 2024 | 10/16/2024 |
4 | Pediatrix Medical Group Q3 2024 Earnings Preview | 10/31/2024 |
5 | Acquisition by C Richards of 45308 shares of Mednax subject to Rule 16b-3 | 11/04/2024 |
6 | Acquisition by Michael Rucker of 8480 shares of Mednax subject to Rule 16b-3 | 11/06/2024 |
7 | Pediatrix Medical Group Price Target Raised to 15.00 | 11/07/2024 |
8 | Pediatrix Medical Group Price Target Raised to 18.00 | 11/08/2024 |
9 | Disposition of 27600 shares by Mark Ordan of Mednax at 15.35 subject to Rule 16b-3 | 11/13/2024 |
10 | Pediatrix Medical Group Upgraded by StockNews.com to Buy Rating | 11/14/2024 |
11 | Should You Consider Adding Pediatrix Medical Group to Your Portfolio | 11/19/2024 |
| Begin Period Cash Flow | 9.8 M |
Mednax |
Mednax Relative Risk vs. Return Landscape
If you would invest 1,124 in Mednax Inc on August 24, 2024 and sell it today you would earn a total of 351.00 from holding Mednax Inc or generate 31.23% return on investment over 90 days. Mednax Inc is generating 0.4907% of daily returns and assumes 3.6125% volatility on return distribution over the 90 days horizon. Put differently, 32% of stocks are less risky than Mednax on the basis of their historical return distribution, and some 91% of all equities are expected to be superior in generating returns on investments over the next 90 days. Expected Return |
| Risk |
Mednax Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Mednax's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Mednax Inc, and traders can use it to determine the average amount a Mednax's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1358
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | MD | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.61 actual daily | 32 68% of assets are more volatile |
Expected Return
| 0.49 actual daily | 9 91% of assets have higher returns |
Risk-Adjusted Return
| 0.14 actual daily | 10 90% of assets perform better |
Based on monthly moving average Mednax is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Mednax by adding it to a well-diversified portfolio.
Mednax Fundamentals Growth
Mednax Stock prices reflect investors' perceptions of the future prospects and financial health of Mednax, and Mednax fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Mednax Stock performance.
| Return On Equity | -0.3 | ||||
| Return On Asset | 0.0467 | ||||
| Profit Margin | (0.13) % | ||||
| Operating Margin | 0.10 % | ||||
| Current Valuation | 1.71 B | ||||
| Shares Outstanding | 85.88 M | ||||
| Price To Earning | 89.39 X | ||||
| Price To Book | 1.70 X | ||||
| Price To Sales | 0.62 X | ||||
| Revenue | 1.99 B | ||||
| Gross Profit | 467.03 M | ||||
| EBITDA | 29.89 M | ||||
| Net Income | (60.41 M) | ||||
| Cash And Equivalents | 9.82 M | ||||
| Cash Per Share | 1.29 X | ||||
| Total Debt | 701.65 M | ||||
| Debt To Equity | 1.03 % | ||||
| Current Ratio | 1.39 X | ||||
| Book Value Per Share | 8.67 X | ||||
| Cash Flow From Operations | 137.32 M | ||||
| Earnings Per Share | (2.34) X | ||||
| Market Capitalization | 1.24 B | ||||
| Total Asset | 2.22 B | ||||
| Retained Earnings | (149.47 M) | ||||
| Working Capital | 94.51 M | ||||
| Current Asset | 527.77 M | ||||
| Current Liabilities | 428.77 M | ||||
About Mednax Performance
By analyzing Mednax's fundamental ratios, stakeholders can gain valuable insights into Mednax's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Mednax has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Mednax has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.07) | (0.07) | |
| Return On Assets | (0.03) | (0.03) | |
| Return On Equity | (0.07) | (0.07) |
Things to note about Mednax Inc performance evaluation
Checking the ongoing alerts about Mednax for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Mednax Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Mednax Inc had very high historical volatility over the last 90 days | |
| The company generated the yearly revenue of 1.99 B. Annual Net Loss to common stockholders was (60.41 M) with gross profit of 467.03 M. | |
| Over 98.0% of the company shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: Should You Consider Adding Pediatrix Medical Group to Your Portfolio |
- Analyzing Mednax's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Mednax's stock is overvalued or undervalued compared to its peers.
- Examining Mednax's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Mednax's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Mednax's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Mednax's stock. These opinions can provide insight into Mednax's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Mednax Stock analysis
When running Mednax's price analysis, check to measure Mednax's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mednax is operating at the current time. Most of Mednax's value examination focuses on studying past and present price action to predict the probability of Mednax's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mednax's price. Additionally, you may evaluate how the addition of Mednax to your portfolios can decrease your overall portfolio volatility.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |